HCA Healthcare, Inc. (NYSE:HCA) Receives $479.00 Consensus PT from Brokerages

HCA Healthcare, Inc. (NYSE:HCA) has been given an average recommendation of “Moderate Buy” by the twenty-four analysts that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $479.00.

Several research analysts recently issued reports on HCA shares. Morgan Stanley lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 target price for the company. in a research report on Monday, December 15th. Stephens increased their price target on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research note on Monday, October 27th. Royal Bank Of Canada upped their target price on HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a report on Friday, December 19th. Truist Financial boosted their price target on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Finally, Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.30% of the company’s stock.

Institutional Investors Weigh In On HCA Healthcare

A number of large investors have recently bought and sold shares of HCA. Saudi Central Bank acquired a new position in shares of HCA Healthcare during the first quarter valued at about $26,000. Palisade Asset Management LLC bought a new position in HCA Healthcare in the third quarter worth approximately $26,000. WPG Advisers LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $27,000. Ameriflex Group Inc. bought a new position in shares of HCA Healthcare in the 2nd quarter worth $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at $27,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $473.78 on Friday. The business has a 50 day moving average of $472.46 and a 200-day moving average of $418.55. HCA Healthcare has a 1 year low of $289.98 and a 1 year high of $520.00. The company has a market capitalization of $108.11 billion, a P/E ratio of 18.31, a P/E/G ratio of 1.39 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts anticipate that HCA Healthcare will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.